Procedure

2017 discharge: European Medicines Agency (EMA)

2018/2185(DEC)·8th term·CONT / ENVI·DEC - Discharge procedure·CompletedProcedure completed
Subjects: 2017 discharge
Rapporteur (the Member appointed to lead Parliament's work on this text): SARVAMAA Petri (PPE)
Summary

This dossier concerns the 2017 discharge for the European Medicines Agency (EMA). The amendments refuse or postpone discharge and address the Agency's staff establishment plan and dependence on external expertise, fees paid by the pharmaceutical industry and conflict-of-interest issues, pre-submission meetings and the role of CHMP, the European Ombudsman's inquiry, and the relocation of the Agency from London to Amsterdam following the United Kingdom's withdrawal from the Union.

Procedure timeline

  1. Committee amendments tabled
    12 Dec 2018 – 31 Jan 2019
  2. Procedure completed
16
Amendments
distinct, in window
9
Members
tabled at least one
2
Committee(s)
12 Dec 2018 – 31 Jan 2019
Dates

Official amendment documents